Mitra RxDx Announces $40 Million Financing Round

Boston, MA, July 11, 2018 - Mitra RxDx (dba Mitra Biotech), a privately held biotech company and global leader in advancing truly personalized oncology treatment, announced today the completion of a $40 million financing round. The round was led by Northpond Ventures,...

read more

Mitra Biotech Receives Innovation Gallery Award

BOSTON, MA, December 4, 2017 – Mitra Biotech, a global leader in advancing the personalization of cancer treatment, has received the “Innovation Gallery Award” at the 2017 CPhI & P-MEC event in Mumbai, India. Mitra was given the award for its innovative CANscript™...

read more